SINGAPORE (July 27): Thomson Medical Group (TMG) has partnered IVI RMA Global, a medical group specialising in assisted reproductive technologies (ART), to set up a Singapore-headquartered ART platform to serve the region.

On Friday, TMG announced that it has entered an exclusive joint venture with IVI-RMA to provide ART clinical services, training and research in Asia. TMG says that the partnership will help it expand its private ART services regionally and become a “dominant” player.

IVI-RMA is one of the largest assisted reproduction groups in the world, with over 70 clinics in Europe and the Americas. It will be setting up its third global research centre in Singapore, to serve this region.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook